Nathanael G. Bailey MD

Dr. Bailey is active on the hematopathology service interpreting lymph node and bone marrow biopsies, reviewing blood films and body fluid specimens, interpreting flow cytometric studies, and providing consultative services on outside lymph node and bone marrow biopsy specimens. He additionally has experience interpreting genetic/genomic assays, and he is involved in bringing on new genetic tests for hematolymphoid neoplasms at the University of Pittsburgh.

Dr. Bailey's research interests include the molecular pathogenesis of hematolymphoid neoplasms and the translation of these findings into routine patient care. He participated in studies that examined the genomic landscape of splenic marginal zone lymphoma, T-cell prolymphocytic leukemia, and Sezary syndrome. Dr. Bailey has led translational studies regarding the efficacy of immunohistochemical detection of mutant BRAF protein in hairy cell leukemia, and is involved in projects evaluating subclassification of peripheral T-cell lymphoma according to its "cell of origin". In addition, Dr. Bailey has written several book chapters and review articles.